Literature DB >> 6106552

Effects of alpha-adrenoceptor agonists and antagonists and of antidepressant drugs on pre- and postsynaptic alpha-adrenoceptors.

J Brown, J C Doxey, S Handley.   

Abstract

The effects of alpha-adrenoceptor agonists and antagonists and of antidepressant drugs were studied on pre- and postsynaptic alpha-adrenoceptors. The rat vas deferens, stimulated at low frequency (0.1 Hz) was used for presynaptic studies. The rat anococcygeus muscle was used in postsynaptic studies. In the agonist studies clonidine and guanfacine were selective for presynaptic alpha-adrenoceptors, methoxamine and phenylephrine were selective for postsynaptic alpha-adrenoceptors and noradrenaline and alpha-methylnoradrenaline were equipotent at pre- and post-synaptic alpha-adrenoceptors. In the antagonist studies piperoxane and yohimbine were selective for presynaptic alpha-adrenoceptors, phentolamine was equipotent at pre- and postsynaptic alpha-adrenoceptors and prazosin was a selective postsynaptic alpha-adrenoceptor antagonist. In the series of antidepressants studied, mianserin was the most potent antagonist at presynaptic alpha-adrenoceptors, followed by trazodone, amitriptyline and nortriptyline in descending order of potency. Mianserin was approximately two hundred times less potent than piperoxane as a presynaptic alpha-adrenoceptor antagonist. Viloxazine and desipramine were inactive. With the exception of viloxazine all of the antidepressants examined possessed postsynaptic alpha-adrenoceptor antagonist properties.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6106552     DOI: 10.1016/0014-2999(80)90005-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  Biochemical pharmacology of paradoxical sleep.

Authors:  J M Gaillard
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  The pharmacology of mianserin--an update.

Authors:  R J Marshall
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

3.  A regional difference in the distribution of postsynaptic alpha-adrenoceptor subtypes in canine veins.

Authors:  T Shoji; H Tsuru; T Shigei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-12       Impact factor: 3.000

4.  The effect of some antidepressants on prejunctional muscarinic receptors on the sympathetic nerves of the isolated rabbit ear artery.

Authors:  Y H Kwok; F Mitchelson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-07       Impact factor: 3.000

5.  The effect of age on the sensitivity of pre- and postsynaptic alpha-adrenoceptors to agonists and antagonists in the rat.

Authors:  R P McAdams; J F Waterfall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

6.  Some pharmacological properties of Wy 27127 a more selective alpha 2:alpha 1-adrenoceptor antagonist than idazoxan in vitro.

Authors:  S J Bill; A Boniface; F Haroun; R P McAdams; N Lattimer; K F Rhodes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

7.  The effects of some alpha-adrenoceptor antagonists on the responses of the canine saphenous vein to B-HT 933, UK-14304 and methoxamine.

Authors:  K F Rhodes; J F Waterfall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

8.  alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system.

Authors:  T L Berridge; B Gadie; A G Roach; I F Tulloch
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

9.  Effects of chronic treatment with antidepressants on aggressiveness induced by clonidine in mice.

Authors:  J Maj; Z Rogóz; G Skuza; H Sowińska
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

10.  Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro.

Authors:  N Lattimer; R P McAdams; K F Rhodes; S Sharma; S J Turner; J F Waterfall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.